Список литературы к главе 6

1. Holmes L.B., Driscoll S.G., Atkins L. Etiologic heterogeneity of neural-tube defects // N. Engl. J. Med. 1976. Vol. 294, N 7. P. 365–369. DOI: 10.1056/NEJM197602122940704.

2. Gabbe S.G. Pregnancy in women with diabetes mellitus. The beginning // Clin. Perinatol. 1993. Vol. 20, N 3. P. 507–515.

3. Hod M., Jovanovic L.G., Di Renzo G.C., de Leiva A. Textbook of diabetes and pregnancy. 2^nd еd. CRC Press, 2008.

4. Zabihi S., Loeken M.R. Understanding diabetic teratogenesis: where are we now and where are we going? // Birth Defects Res. A Clin. Mol. Teratol. 2010. Vol. 88, N 10. P. 779–790. DOI: 10.1002/bdra.20704.

5. Agha M.M., Glazier R.H., Moineddin R., Booth G. Congenital abnormalities in newborns of women with pregestational diabetes: a time-trend analysis, 1994 to 2009 // Birth Defects Res. A Clin. Mol. Teratol. 2016. Vol. 106, N 10. P. 831–839. DOI: 10.1002/bdra.23548.

6. Billionnet C., Mitanchez D., Weill A., Nizard J., Alla F., Hartemann A., Jacqueminet S. Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012 // Diabetologia. 2017. Vol. 60, N 4. P. 636–644. DOI: 10.1007/s00125-017-4206-6.

7. Liu S., Rouleau J., León J.A., Sauve R., Joseph K.S., Ray J.G. et al. Impact of pre-pregnancy diabetes mellitus on congenital anomalies, Canada, 2002–2012 // Health Promot. Chronic. Dis. Prev. Can. 2015. Vol. 35, N 5. P. 79–84. DOI: 10.24095/hpcdp.35.5.01.

8. Parimi M., Nitsch D. A Systematic review and meta-analysis of diabetes during pregnancy and congenital genitourinary abnormalities // Kidney Int. Rep. 2020. Vol. 5, N 5. P. 678–693. DOI: 10.1016/j.ekir.2020.02.1027.

9. Kappen C., Salbaum J.M. Gene expression in teratogenic exposures: a new approach to understanding individual risk // Reprod. Toxicol. 2014. Vol. 45. P. 94–104. DOI: 10.1016/j.reprotox.2013.12.008.

10. HAPO Study Cooperative Research Group, Metzger B.E., Lowe L.P., Dyer A.R., Trimble E.R., Chaovarindr U. et al. Hyperglycemia and adverse pregnancy outcomes // N. Engl. J. Med. 2008. Vol. 358, N 19. P. 1991–2002. DOI: 10.1056/NEJMoa0707943.

11. Wahabi H., Fayed A., Esmaeil S., Mamdouh H., Kotb R. Prevalence and Complications of Pregestational and Gestational Diabetes in Saudi Women: Analysis from Riyadh Mother and Baby Cohort Study (RAHMA) // Biomed. Res. Int. 2017. Vol. 2017. P. 6878263. DOI: 10.1155/2017/6878263.

12. Floris I., Descamps B., Vardeu A., Mitić T., Posadino A.M., Shantikumar S. et al. Gestational diabetes mellitus impairs fetal endothelial cell functions through a mechanism involving microRNA-101 and histone methyltransferase enhancer of zester homolog-2 // Arterioscler Thromb. Vasc. Biol. 2015. Vol. 35, N 3. P. 664–674. DOI: 10.1161/ATVBAHA.114.304730.

13. Ornoy A., Reece E.A., Pavlinkova G., Kappen C., Miller R.K. Effect of maternal diabetes on the embryo, fetus, and children: congenital anomalies, genetic and epigenetic changes and developmental outcomes // Birth Defects Res. C. Embryo. Today. 2015. Vol. 105, N 1. P. 53–72. DOI: 10.1002/bdrc.21090.

14. Liu S., Evans J., MacFarlane A.J., Ananth C.V., Little J., Kramer M.S., Joseph K.S. Association of maternal risk factors with the recent rise of neural tube defects in Canada // Paediatr. Perinat. Epidemiol. 2019. Vol. 33, N 2. P. 145–153. DOI: 10.1111/ppe.12543.

15. Rudge M.V., Calderon I.M., Ramos M.D., Abbade J.F., Rugolo L.M. Perinatal outcome of pregnancies complicated by diabetes and by maternal daily hyperglycemia not related to diabetes. A retrospective 10-year analysis // Gynecol. Obstet. Invest. 2000. Vol. 50, N 2. P. 108–112. DOI: 10.1159/000010293.

16. White P. Pregnancy complicating diabetes // Am. J. Med. 1949. Vol. 7, N 5. P. 609–616. DOI: 10.1016/0002-9343(49)90382-4.

17. Евсюкова И.И., Кошелева Н.Г. Сахарный диабет: беременные и новорожденные. Москва: Миклош, 2009. 272 с.

18. Айламазян Э.К., Абашова Е.И., Коган И.Ю. и др. Сахарный диабет и репродуктивная система женщины: руководство для врачей. Москва: ГЭОТАР-Медиа, 2019. 432 с.

19. Allen V.M., Armson B.A.; GENETICS COMMITTEE; MATERNAL FETAL MEDICINE COMMITTEE. Teratogenicity associated with pre-existing and gestational diabetes // J. Obstet. Gynaecol. Can. 2007. Vol. 29, N 11. P. 927–934. DOI: 10.1016/S1701-2163(16)32653-6.

20. Hunter L.E., Sharland G.K. Maternal gestational diabetes and fetal congenital heart disease: an observational study // J. Pregnancy Child. Heal. 2015. Vol. 2. DOI: 10.4172/2376-127X.1000132.

21. Ahmed B., Abushama M., Khraisheh M., Dudenhausen J. Role of ultrasound in the management of diabetes in pregnancy // J. Matern. Neonatal. Med. 2015. Vol. 28. P. 1856–1863. DOI: 10.3109/14767058.2014.971745.

22. International Diabetes Federation. IDF Diabetes Atlas, 9th ed. Brussels, 2019.

23. Mills J.L., Simpson J.L., Driscoll S.G., Jovanovic-Peterson L., Van Allen M., Aarons J.H. et al. Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception // N. Engl. J. Med. 1988. Vol. 319, N 25. P. 1617–1623. DOI: 10.1056/NEJM198812223192501.

24. Аметов А.С., Соловьева О.Л. Сердечно-сосудистые осложнения при сахарном диабете: патогенез и пути коррекции // РМЖ. 2011. Т. 19. С. 1694–1699.

25. Coughlan M.T., Permezel M., Georgiou H.M., Rice G.E. Repression of oxidant-induced nuclear factor-κB activity mediates placental cytokine responses in gestational diabetes // J. Clin. Endocrinol. Metab. 2004. Vol. 89. P. 3585–3594. DOI: 10.1210/jc.2003-031953.

26. Díaz-Pérez F.I., Hiden U., Gauster M., Lang I., Konya V., Heinemann A. et al. Post-transcriptional down regulation of ICAM-1 in feto-placental endothelium in GDM // Cell Adhes. Migr. 2016. Vol. 10. P. 18–27. DOI: 10.1080/19336918.2015.1127467.

27. Jauniaux E., Hempstock J., Greenwold N., Burton G.J. Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies // Am. J. Pathol. 2003. Vol. 162. P. 115–125. DOI: 10.1016/S0002-9440(10)63803-5.

28. Rasouli N., Kern P.A. Adipocytokines and the metabolic complications of obesity // J. Clin. Endocrinol. Metab. 2008. Vol. 93, N 11. Suppl. 1. P. S64–S73. DOI: 10.1210/jc.2008-1613.

29. Galic S., Oakhill J.S., Steinberg G.R. Adipose tissue as an endocrine organ // Mol. Cell Endocrinol. 2010 Vol. 316. P. 129–139. DOI: 10.1016/j.mce.2009.08.018.

30. Henry B.A., Clarke I.J. Adipose tissue hormones and the regulation of food intake // J. Neuroendocrinol. 2008. Vol. 20, N 6. P. 842–849. DOI: 10.1111/j.1365-2826.2008.1730.x.

31. Kapustin R.V., Drobintseva A.O., Alekseenkova E.N., Onopriychuk A.R., Arzhanova O.N., Polyakova V.O., Kvetnoy I.M. Placental protein expression of kisspeptin-1 (KISS1) and the kisspeptin-1 receptor (KISS1R) in pregnancy complicated by diabetes mellitus or preeclampsia // Arch. Gynecol. Obstet. 2020. Vol. 301, N 2. P. 437–445. DOI: 10.1007/s00404-019-05408-1.

32. Kitzmiller J.L., Block J.M., Brown F.M., Catalano P.M., Conway D.L., Coustan D.R. et al. Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care // Diabetes Care. 2008. Vol. 31, N 5. P. 1060–1079. DOI: 10.2337/dc08-9020.

33. Eriksson U.J., Wentzel P. The status of diabetic embryopathy // Ups. J. Med. Sci. 2016. Vol. 121, N 2. P. 96–112. DOI: 10.3109/03009734.2016.1165317.

34. De Franco S., Chiocchetti A., Ferretti M., Castelli L., Cadario F., Cerutti F. et al. Defective function of the Fas apoptotic pathway in type 1 diabetes mellitus correlates with age at onset // Int. J. Immunopathol. Pharmacol. 2007. Vol. 20, N 3. P. 567–576. DOI: 10.1177/039463200702000314.

35. Ding Z., Zhou H., McCauley N., Ko G., Zhang K.K., Xie L. In ovo hyperglycemia causes congenital limb defects in chicken embryos via disruption of cell proliferation and apoptosis // Biochim. Biophys. Acta. Mol. Basis. Dis. 2020. Vol. 1866, N 12. P. 165955. DOI: 10.1016/j.bbadis.2020.165955.

36. Freinkel N., Cockroft D.L., Lewis N.J., Gorman L., Akazawa S., Phillips L.S., Shambaugh G.E. 3rd. The 1986 McCollum award lecture. Fuel-mediated teratogenesis during early organogenesis: the effects of increased concentrations of glucose, ketones, or somatomedin inhibitor during rat embryo culture // Am. J. Clin. Nutr. 1986. Vol. 44, N 6. P. 986–995. DOI: 10.1093/ajcn/44.6.986.

37. Mills J.L., Knopp R.H., Simpson J.L., Jovanovic-Peterson L., Metzger B.E., Holmes L.B. et al. Lack of relation of increased malformation rates in infants of diabetic mothers to glycemic control during organogenesis // N. Engl. J. Med. 1988. Vol. 318. P. 671–676. DOI: 10.1056/NEJM198803173181104.

38. Greene M.F. Spontaneous abortions and major malformations in women with diabetes mellitus // Semin. Reprod. Endocrinol. 1999. Vol. 17, N 2. P. 127–136. DOI: 10.1055/s-2007-1016220.

39. Cundy T., Gamble G., Neale L., Elder R., McPherson P. et al. Differing causes of pregnancy loss in type 1 and type 2 diabetes // Diabetes Care. 2007. Vol. 30, N 10. P. 2603–2607. DOI: 10.2337/dc07-0555.

40. Gutaj P., Zawiejska A., Wender-Ożegowska E., Brązert J. Maternal factors predictive of first-trimester pregnancy loss in women with pregestational diabetes // Pol. Arch. Med. Wewn. 2013. Vol. 123, N 1–2. P. 21–28. DOI: 10.20452/pamw.1585.

41. Rosenn B.M., Miodovnik M., Holcberg G., Khoury J.C., Siddiqi T.A. Hypoglycemia: the price of intensive insulin therapy for pregnant women with insulin-dependent diabetes mellitus // Obstet. Gynecol. 1995. Vol. 85, N 3. P. 417–422. DOI: 10.1016/0029-7844(94)00415-A.

42. Zisser H.C., Biersmith M.A., Jovanovič L.B., Yogev Y., Hod M., Kovatchev B.P. Fetal risk assessment in pregnancies complicated by diabetes mellitus // J. Diabetes Sci. Technol. 2010. Vol. 4. P. 1368–1373. DOI: 10.1177/193229681000400610.

43. Jovanovic L., Knopp R.H., Kim H., Cefalu W.T., Zhu X.D., Lee Y.J. et al. Elevated pregnancy losses at high and low extremes of maternal glucose in early normal and diabetic pregnancy: evidence for a protective adaptation in diabetes // Diabetes Care. 2005. Vol. 28, N 5. P. 1113–1117. DOI: 10.2337/diacare.28.5.1113.

44. Casson I.F., Clarke C.A., Howard C.V., McKendrick O., Pennycook S., Pharoah P.O. et al. Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study // BMJ. 1997. Vol. 315, N 7103. P. 275–278. DOI: 10.1136/bmj.315.7103.275.

45. Sacks D.A., Feig D.S. Caring for pregnant women whose diabetes antedates pregnancy: is there room for improvement? // Diabetologia. 2018. Vol. 61, N 5. P. 1022–1026. DOI: 10.1007/s00125-018-4565-7.

46. Murphy H.R., Bell R., Cartwright C., Curnow P., Maresh M., Morgan M. et al. Improved pregnancy outcomes in women with type 1 and type 2 diabetes but substantial clinic-to-clinic variations: a prospective nationwide study // Diabetologia. 2017. Vol. 60, N 9. P. 1668–1677. DOI: 10.1007/s00125-017-4314-3.

47. Айламазян Э.К., Боровик Н.В., Потин В.В., Тиселько А.В. Подготовка женщин с сахарным диабетом к беременности // Доктор Ру. 2014. Т. 12. С. 34–38.

48. Гафарова Е.А., Замалеева Р.С., Коган Я.Э. Особенности прегравидарной подготовки женщин с нарушениями углеводного обмена и риском развития гестационного диабета // Практическая медицина. 2017. № 7 (108). С. 41–46.

49. Ших Е.В., Махова А.А. Преимущества проведения коррекции фолатного статуса с использованием витаминно-минерального комплекса, содержащего Метафолин // Трудный пациент. 2013. № 11. С. 26–31.

50. Araújo J.R., Correia-Branco A., Moreira L., Ramalho C., Martel F., Keating E. Folic acid uptake by the human syncytiotrophoblast is affected by gestational diabetes, hyperleptinemia, and TNF-α // Pediatr. Res. 2013. Vol. 73, N 4. Pt. 1. P. 388–394. DOI: 10.1038/pr.2013.14.